Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Flexion Therapeutics (FLXN)

Flexion Therapeutics (FLXN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 686,959
  • Shares Outstanding, K 38,175
  • Annual Sales, $ 22,520 K
  • Annual Income, $ -169,660 K
  • 60-Month Beta 1.47
  • Price/Sales 11.62
  • Price/Cash Flow N/A
  • Price/Book 97.80

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -1.00
  • Number of Estimates 2
  • High Estimate -0.98
  • Low Estimate -1.03
  • Prior Year -1.07
  • Growth Rate Est. (year over year) +6.54%

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.35 +2.77%
on 01/17/20
22.98 -22.41%
on 12/27/19
-1.36 (-7.09%)
since 12/24/19
3-Month
14.63 +21.91%
on 11/08/19
22.98 -22.41%
on 12/27/19
+2.33 (+15.03%)
since 10/24/19
52-Week
8.76 +103.54%
on 08/05/19
22.98 -22.41%
on 12/27/19
+4.43 (+33.06%)
since 01/24/19

Most Recent Stories

More News
22.5% Return Seen to Date on SmarTrend Flexion Therapeu Call (FLXN)

SmarTrend identified an Uptrend for Flexion Therapeu (NASDAQ:FLXN) on October 23rd, 2019 at $14.96. In approximately 3 months, Flexion Therapeu has returned 22.50% as of today's recent price of $18.32....

FLXN : 18.00 (unch)
Flexion Therapeu Shares Up 22.0% Since SmarTrend's Buy Recommendation (FLXN)

SmarTrend identified an Uptrend for Flexion Therapeu (NASDAQ:FLXN) on October 23rd, 2019 at $14.96. In approximately 3 months, Flexion Therapeu has returned 21.97% as of today's recent price of $18.24....

FLXN : 18.00 (unch)
Watch for Flexion Therapeu to Potentially Rebound After Falling 5.44% Yesterday

Flexion Therapeu (NASDAQ:FLXN) traded in a range yesterday that spanned from a low of $19.53 to a high of $20.86. Yesterday, the shares fell 5.4%, which took the trading range below the 3-day low of...

FLXN : 18.00 (unch)
Flexion Therapeutics Announces Preliminary, Unaudited Fourth-Quarter and Full-Year 2019 Revenue and Initial Revenue Guidance for 2020

Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced preliminary and unaudited revenue for the fourth-quarter and full-year ended December 31, 2019 and provided initial revenue guidance for 2020.

FLXN : 18.00 (unch)
Uptrend Call Working As Flexion Therapeu Stock Rises 36.8% (FLXN)

SmarTrend identified an Uptrend for Flexion Therapeu (NASDAQ:FLXN) on October 23rd, 2019 at $14.96. In approximately 3 months, Flexion Therapeu has returned 36.78% as of today's recent price of $20.46....

FLXN : 18.00 (unch)
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced equity inducement grants to five new employees consisting of an aggregate of 17,000 stock options and 2,800 restricted stock units. The Compensation...

FLXN : 18.00 (unch)
Is the Options Market Predicting a Spike in Flexion (FLXN) Stock?

Investors need to pay close attention to Flexion (FLXN) stock based on the movements in the options market lately.

FLXN : 18.00 (unch)
Flexion's (FLXN) Stock Up on FDA Approval for Zilretta sNDA

Flexion's (FLXN) sNDA for osteoarthritis drug, Zilretta, seeking removal of confusing limitation of use label, gets FDA approval.

CHRS : 18.63 (-0.48%)
ALKS : 17.39 (-4.45%)
BDSI : 5.85 (+0.52%)
FLXN : 18.00 (unch)
Michaels and Flexion Therapeutics rise; Darden declines

NEW YORK (AP) — Stocks that moved substantially or traded heavily on Friday:

FLXN : 18.00 (unch)
AXE : 98.96 (-0.16%)
DRI : 117.68 (+0.05%)
LNC : 56.90 (-2.45%)
RH : 223.07 (-1.23%)
AAL : 27.61 (-4.13%)
Watch for Flexion Therapeu to Potentially Pullback After Gaining 14.16% Yesterday

Flexion Therapeu (NASDAQ:FLXN) traded in a range yesterday that spanned from a low of $20.68 to a high of $22.98. Yesterday, the shares gained 14.2%, which took the trading range above the 3-day high...

FLXN : 18.00 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade FLXN with:

Business Summary

Flexion Therapeutics, Inc. is a specialty pharmaceutical company. It is focused on the development and commercialization of injectable pain therapies. The Company is targeting anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions. It operates in the United...

See More

Key Turning Points

2nd Resistance Point 18.51
1st Resistance Point 18.25
Last Price 18.00
1st Support Level 17.82
2nd Support Level 17.65

See More

52-Week High 22.98
Last Price 18.00
Fibonacci 61.8% 17.55
Fibonacci 50% 15.87
Fibonacci 38.2% 14.19
52-Week Low 8.76

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar